Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma

Clinical and Experimental Allergy

Volumn 44, Issue 12, 2014, Pages 1546-1557

  Trzil, J E ^a   Masseau, I ^a   Webb, T L ^b   Chang, C H ^c   Dodam, J R ^a   Cohn, L A ^a   Liu, H ^a   Quimby, J M ^b   Dow, S W ^b   Reinero, C R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Airflow limitation; Airway eosinophilia; Airway remodelling; Allogeneic stem cell therapy; Animal model

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 10;

ADVERSE EFFECTS; AIRWAY REMODELING; ANIMAL; ASTHMA; BLOOD; BRONCHUS HYPERREACTIVITY; CAT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOPHYSIOLOGY;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CATS; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84911399050     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12411     Document Type: Article

References (50)

1. Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010; 299:L760-70.
2. Goodwin M, Sueblinvong V, Eisenhauer P et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 2011; 29:1137-48.
3. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 2011; 66:523-31.
4. Lee SH, Jang AS, Kwon JH, Park SK, Won JH, Park CS. Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol Res 2011; 3:205-11.
5. Park HK, Cho KS, Park HY et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 2010; 19:1811-8.
6. Firinci F, Karaman M, Baran Y et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011; 11:1120-6.
7. Nemeth K, Keane-Myers A, Brown JM et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A 2010; 107:5652-7.
8. Ou-Yang HF, Han XP, Zhao F, Ti XY, Wu CG. The role of bone marrow-derived adult stem cells in a transgenic mouse model of allergic asthma. Respiration 2012; 83:74-80.
9. Harding J, Roberts RM, Mirochnitchenko O. Large animal models for stem cell therapy. Stem Cell Res Ther 2013; 4:23.
10. Hein WR, Griebel PJ. A road less travelled: Large animal models in immunological research. Nat Rev Immunol 2003; 3:79-84.
11. Krug N, Rabe KF. Animal models for human asthma: the perspective of a clinician. Curr Drug Targets 2008; 9:438-42.
12. Dye JA, McKiernan BC, Rozanski EA et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996; 10:385-400.
13. Moise NS, Wiedenkeller D, Yeager AE, Blue JT, Scarlett J. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 1989; 194:1467-73.
14. Reinero CR, DeClue AE, Rabinowitz P. Asthma in humans and cats: is there a common sensitivity to aeroallegens in shared environments? Environ Res 2009; 109:634-40.
15. Reinero CR. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma. Vet J 2011; 190:28-33.
16. O'Brien SJ, Wienberg J, Lyons LA. Comparative genomics: lessons from cats. Trends Genet 1997; 13:393-9.
17. Norris Reinero CR, Decile KC, Berghaus RD et al. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int Arch Allergy Immunol 2004; 135:117-31.
18. Reinero C, Lee-Fowler T, Chang CH, Cohn L, Declue A. Beneficial cross-protection of allergen-specific immunotherapy on airway eosinophilia using unrelated or a partial repertoire of allergen(s) implicated in experimental feline asthma. Vet J 2012; 192:412-6.
19. Jang HJ, Cho KS, Park HY, Roh HJ. Adipose tissue-derived stem cells for cell therapy of airway allergic diseases in mouse. Acta Histochem 2011; 113:501-7.
20. Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther 2013; 4:48.
21. Webb TL, Quimby JM, Dow SW. In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J Feline Med Surg 2012; 14:165-8.
22. Marinas-Pardo L, Mirones I, Amor-Carro O et al. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma. Allergy 2014; 69:730-40.
23. Martinez-Gonzalez I, Cruz MJ, Moreno R, Morell F, Munoz X, Aran JM. Human mesenchymal stem cells resolve airway inflammation, hyperreactivity, and histopathology in a mouse model of occupational asthma. Stem Cells Dev 2014; 23:2352-63.
24. Quimby JM, Webb TL, Gibbons DS, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Feline Med Surg 2011; 13:418-26.
25. Daniel WW. Biostastistics: a foundation for analysis in the health sciences. 7th edn. New York, NY: John Wiley and Sons, Inc, 1999.
26. Nafe LA, Guntur VP, Dodam JR, Lee-Fowler TM, Cohn LA, Reinero CR. Nebulized lidocaine blunts airway hyper-responsiveness in experimental feline asthma. J Feline Med Surg 2013; 15:712-6.
27. Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991; 18:1520-8.
28. Ketai L, Coutsias C, Williamson S, Coutsias V. Thin-section CT evidence of bronchial thickening in children with stable asthma: bronchoconstriction or airway remodeling? Acad Radiol 2001; 8:257-64.
29. Chang CH, Lee-Fowler TM, Declue AE, Cohn LA, Robinson KL, Reinero CR. The impact of oral versus inhaled glucocorticoids on allergen specific IgE testing in experimentally asthmatic cats. Vet Immunol Immunopathol 2011; 144:437-41.
30. Lee-Fowler TM, Guntur V, Dodam J, Cohn LA, DeClue AE, Reinero CR. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int Arch Allergy Immunol 2012; 158:369-74.
31. Reinero CR, Liu H, Chang CH. Flow cytometric determination of allergen-specific T lymphocyte proliferation from whole blood in experimentally asthmatic cats. Vet Immunol Immunopathol 2012; 149:1-5.
32. Buc M, Dzurilla M, Vrlik M, Bucova M. Immunopathogenesis of bronchial asthma. Arch Immunol Ther Exp (Warsz) 2009; 57:331-44.
33. Halwani R, Al-Muhsen S, Hamid Q. Airway remodeling in asthma. Curr Opin Pharmacol 2010; 10:236-45.
34. Ge X, Bai C, Yang J, Lou G, Li Q, Chen R. Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma. J Cell Biochem 2013; 114:1595-605.
35. Ge X, Bai C, Yang J, Lou G, Li Q, Chen R. Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4(+)CD25(+) regulatory T cells in asthmatic mouse. Cell Biol Int 2013; 37:675-86.
36. Orihara K, Dil N, Anaparti V, Moqbel R. What's new in asthma pathophysiology and immunopathology? Expert Rev Respir Med 2010; 4:605-29.
37. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011; 6:457-78.
38. Bates J, Irvin C, Brusasco V et al. The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004; 31:373-4.
39. Busse WW. The relationship of airway hyperresponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138:4S-10S.
40. Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives J Allergy Clin Immunol Pract 2011; 128:439-48; quiz 49-50.
41. Chang JC, Summer R, Sun X, Fitzsimmons K, Fine A. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 2005; 33:335-42.
42. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005; 33:328-34.
43. Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 2008; 3:531-46.
44. Grainge CL, Lau LC, Ward JA et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011; 364:2006-15.
45. Martinez FD, Vercelli D. Asthma. Lancet 2013; 382:1360-72.
46. McEntee MC, Page RL. Feline vaccine-associated sarcomas. J Vet Intern Med 2001; 15:176-82.
47. Hartmann K. Clinical aspects of feline retroviruses: a review. Viruses 2012; 4:2684-710.
48. Aberdein D, Munday JS, Dyer CB, Knight CG, French AF, Gibson IR. Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in New Zealand. N Z Vet J 2007; 55:203-7.
49. Ra JC, Shin IS, Kim SH et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011; 20:1297-308.
50. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211:27-35.